Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Rabivax-S in Individuals Receiving Pre-exposure Prophylaxis (PrEP)
NCT03741270Phase 4Completed
- Sponsor
- Ross University School of Veterinary Medicine
- Start
- Oct 2018
- Primary completion
- Mar 2019
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rabies virus inactivated antigen, A in rabies, sponsored by Ross University School of Veterinary Medicine. Primary endpoint: Number of participants with at least one solicited adverse event (AE). Started Oct 2018; status: completed.
02
Drugs
rabies virus inactivated antigen, A
03
Conditions
rabies
Beyond the preview
Go deeper on NCT03741270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03741270.